Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ≥50%: real-world data.

Antibodies, Monoclonal, Humanized B7-H1 Antigen / genetics Carcinoma, Non-Small-Cell Lung / drug therapy Female Humans In Situ Hybridization, Fluorescence Lung Neoplasms / drug therapy Platinum Prospective Studies Proto-Oncogene Mas Proto-Oncogene Proteins / genetics
PD-L1 Pembrolizumab lung cancer pembrolizumab chemotherapy real world

Journal

Oncoimmunology
ISSN: 2162-402X
Titre abrégé: Oncoimmunology
Pays: United States
ID NLM: 101570526

Informations de publication

Date de publication:
28 01 2021
Historique:
entrez: 8 2 2021
pubmed: 9 2 2021
medline: 29 7 2021
Statut: epublish

Résumé

Both pembrolizumab (P) and combination of pembrolizumab with platinum-based chemotherapy (PCT) represent standard 1

Identifiants

DOI: 10.1080/2162402X.2020.1865653 PMID: 33552685 PMC: PMC7849771
pubmed: 33552685
doi: 10.1080/2162402X.2020.1865653
pii: 1865653
pmc: PMC7849771
doi:

Substances chimiques

Antibodies, Monoclonal, Humanized 0
B7-H1 Antigen 0
MAS1 protein, human 0
Proto-Oncogene Mas 0
Proto-Oncogene Proteins 0
Platinum 49DFR088MY
pembrolizumab DPT0O3T46P

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1865653

Informations de copyright

© 2021 The Author(s). Published with license by Taylor & Francis Group, LLC.

Références

N Engl J Med. 2018 Jun 14;378(24):2288-2301
pubmed: 29863955
J Thorac Oncol. 2020 Oct;15(10):1636-1646
pubmed: 32781263
N Engl J Med. 2018 Nov 22;379(21):2040-2051
pubmed: 30280635
N Engl J Med. 2016 Nov 10;375(19):1823-1833
pubmed: 27718847
J Clin Oncol. 2020 Jan 1;38(1):1-10
pubmed: 31682550
N Engl J Med. 2018 May 31;378(22):2093-2104
pubmed: 29658845
Mol Cancer. 2018 Aug 23;17(1):129
pubmed: 30139382
N Engl J Med. 2018 May 31;378(22):2078-2092
pubmed: 29658856
J Clin Oncol. 2018 Mar 1;36(7):633-641
pubmed: 29337640
Lancet. 2019 May 4;393(10183):1819-1830
pubmed: 30955977
J Natl Cancer Inst. 2019 Aug 1;111(8):772-781
pubmed: 31106827
Lung Cancer. 2019 Aug;134:127-140
pubmed: 31319971
Cancer Med. 2019 Sep;8(11):5033-5046
pubmed: 31297962
Genome Med. 2017 Apr 19;9(1):34
pubmed: 28420421
J Immunother Cancer. 2019 May 3;7(1):120
pubmed: 31053172
Nat Commun. 2020 Apr 14;11(1):1779
pubmed: 32286310
N Engl J Med. 2015 May 21;372(21):2018-28
pubmed: 25891174
J Clin Oncol. 2019 Mar 1;37(7):537-546
pubmed: 30620668
Biomedicines. 2020 Jul 21;8(7):
pubmed: 32708265
Lancet Oncol. 2018 Jun;19(6):737-746
pubmed: 29778737
J Clin Oncol. 2020 May 10;38(14):1505-1517
pubmed: 32150489
Lancet Oncol. 2019 Jul;20(7):924-937
pubmed: 31122901
J Immunother Cancer. 2018 Dec 22;6(1):155
pubmed: 30577837

Auteurs

Elizabeth Dudnik (E)

Thoracic Cancer Service, Davidoff Cancer Center, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
ORCID: 0000-0001-6971-3576

Mor Moskovitz (M)

Oncology Department, Thoracic Cancer Service, Rambam Health Care Campus, Haifa, Israel.

Yakir Rottenberg (Y)

Oncology Department, Hadassah Medical Center, Jerusalem, Israel.
Hebrew University of Jerusalem, Hadassah Medical Center, Jerusalem, Israel.

Anastasiya Lobachov (A)

Thoracic Cancer Service, Institute of Oncology, Sheba Medical Center, Ramat Gan, Israel.

Rinat Mandelboim (R)

Thoracic Cancer Service, Davidoff Cancer Center, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel.

Tzippy Shochat (T)

Statistical Consulting Unit, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel.

Damien Urban (D)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Thoracic Cancer Service, Institute of Oncology, Sheba Medical Center, Ramat Gan, Israel.

Mira Wollner (M)

Oncology Department, Thoracic Cancer Service, Rambam Health Care Campus, Haifa, Israel.

Hovav Nechushtan (H)

Oncology Department, Hadassah Medical Center, Jerusalem, Israel.
Hebrew University of Jerusalem, Hadassah Medical Center, Jerusalem, Israel.

Ofer Rotem (O)

Thoracic Cancer Service, Davidoff Cancer Center, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel.

Alona Zer (A)

Thoracic Cancer Service, Davidoff Cancer Center, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Sameh Daher (S)

Thoracic Cancer Service, Institute of Oncology, Sheba Medical Center, Ramat Gan, Israel.

Jair Bar (J)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Thoracic Cancer Service, Institute of Oncology, Sheba Medical Center, Ramat Gan, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Globulines › Sérum-globulines › Immunoglobulines › Anticorps › Anticorps monoclonaux › Anticorps monoclonaux humanisés › Pembrolizumab as a monotherapy or in...
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Antigènes B7 › Antigène CD274 › Pembrolizumab as a monotherapy or in...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Tumeurs de l'appareil respiratoire › Tumeurs du poumon › Tumeurs des bronches › Carcinome bronchogénique › Carcinome pulmonaire non à petites cellules › Pembrolizumab as a monotherapy or in...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Pembrolizumab as a monotherapy or in...
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Hybridation in situ › Hybridation fluorescente in situ › Pembrolizumab as a monotherapy or in...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Tumeurs de l'appareil respiratoire › Tumeurs du poumon › Pembrolizumab as a monotherapy or in...
questionsmedicales.fr › Produits chimiques inorganiques › Métaux › Métaux lourds › Platine › Pembrolizumab as a monotherapy or in...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études prospectives › Pembrolizumab as a monotherapy or in...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines tumorales › Protéines oncogènes › Protéines proto-oncogènes › Proto-oncogène Mas › Pembrolizumab as a monotherapy or in...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines tumorales › Protéines oncogènes › Protéines proto-oncogènes › Pembrolizumab as a monotherapy or in...